Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-MYOD1 Antibody (R3D89)

Catalog #:   RHD09401 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, IF
Accession: P15172
Overview

Catalog No.

RHD09401

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400, IF: 1:50-1:200

Target

MYOD, bHLHc1, Myoblast determination protein 1, Class C basic helix-loop-helix protein 1, Myf-3, BHLHC1, MYOD1, Myogenic factor 3, MYF3

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P15172

Applications

ELISA, FCM, IF

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3D89

Data Image
  • Flow Cytometry
    Flow cytometric analysis of Hela cells using MYOD1 mouse mAb (green) and negative control (red).
  • Immunofluorescence
    Immunofluorescence analysis of Hela cells using MYOD1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.
References

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma., PMID:39043633

MicroRNA-542-3p targets Pten to inhibit the myoblasts proliferation but suppresses myogenic differentiation independent of targeted Pten., PMID:38561670

A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature review., PMID:37735390

A Semi-Three-Dimensional Bioprinted Neurocardiac System for Tissue Engineering of a Cardiac Autonomic Nervous System Model., PMID:37508861

Multifaceted Spindle Cell/Sclerosing Rhabdomyosarcoma With Role of Immunohistochemistry in Avoiding Misdiagnosis: A Multi-Institutional Study of 45 Distinct Tumors., PMID:37489265

[Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation]., PMID:36785957

The role of spinal cord tractography in detecting lesions following selective bladder afferent and efferent fibers injury: A novel method for induction of neurogenic lower urinary tract dysfunction in rabbit., PMID:35842827

Comparing the epigenetic landscape in myonuclei purified with a PCM1 antibody from a fast/glycolytic and a slow/oxidative muscle., PMID:34752468

Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT)., PMID:34638431

Simple derivation of skeletal muscle from human pluripotent stem cells using temperature-sensitive Sendai virus vector., PMID:34510713

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium., PMID:34166060

Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma., PMID:33691532

"Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor"., PMID:33318583

The effect of growth factors on induction of mesenchymal stem cell to the skeletal muscle cells., PMID:33300353

Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage., PMID:32614850

Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence in situ Hybridization., PMID:32581037

[Analysis of clinicopathological features of clear cell tumor of the lung]., PMID:32536096

Multiplexed RNAscope and immunofluorescence on whole-mount skeletal myofibers and their associated stem cells., PMID:31519691

Short-term influences of radiation on musculofascial healing in a laparotomy rat model., PMID:31417127

Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity., PMID:31268746

Analysis of Stem Cells and Their Activity in Human Skeletal Muscles by Immunohistochemistry., PMID:30989506

Isolation and Culture of Individual Myofibers and Their Adjacent Muscle Stem Cells from Aged and Adult Skeletal Muscle., PMID:30838602

Chick embryonic cells as a source for generating in vitro model of muscle cell dystrophy., PMID:30302616

Influence of static magnetic fields on human myoblast/mesenchymal stem cell co‑cultures., PMID:29286120

The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA., PMID:28918507

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells., PMID:28654079

Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles., PMID:26515458

Detection of satellite cells during skeletal muscle wound healing in rats: time-dependent expressions of Pax7 and MyoD in relation to wound age., PMID:26311174

Long-Term Endurance Exercise in Humans Stimulates Cell Fusion of Myoblasts along with Fusogenic Endogenous Retroviral Genes In Vivo., PMID:26154387

Rhabdomyosarcoma of Soft Tissues in an Adult Brook Trout (Salvelinus fontinalis)., PMID:26072379

Expression of Non-acetylatable H2A.Z in Myoblast Cells Blocks Myoblast Differentiation through Disruption of MyoD Expression., PMID:25839232

Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice., PMID:24655377

Dynamic expression of molecules that control limb muscle development including Fhl1 in hind limbs of different gestational age., PMID:24475781

Regulation of eukaryotic initiation factor 4AII by MyoD during murine myogenic cell differentiation., PMID:24466343

Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression., PMID:23995658

Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain., PMID:23794713

Transforming growth factor-β1 (TGF-β1) regulates cell junction restructuring via Smad-mediated repression and clathrin-mediated endocytosis of nectin-like molecule 2 (Necl-2)., PMID:23741316

Promotion of muscle regeneration by myoblast transplantation combined with the controlled and sustained release of bFGFcpr., PMID:23554408

Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma., PMID:22577581

Myogenic capacity of muscle progenitor cells from head and limb muscles., PMID:22288919

Joint inflammation alters gene and protein expression and leads to atrophy in the tibialis anterior muscle in rats., PMID:21959222

Impact of static magnetic fields on human myoblast cell cultures., PMID:21837362

Emerin inhibits Lmo7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes., PMID:21525034

Hes6 is required for actin cytoskeletal organization in differentiating C2C12 myoblasts., PMID:21501606

Mitogen-activated protein kinase kinase 1 (MEK1) stabilizes MyoD through direct phosphorylation at tyrosine 156 during myogenic differentiation., PMID:21454680

Low-magnitude vertical vibration enhances myotube formation in C2C12 myoblasts., PMID:20634357

Rat monoclonal antibody specific for MyoD., PMID:20569002

Rhabdomyosarcoma of the head and neck: a clinicopathological and immunohistochemical analysis of 29 cases., PMID:20464324

Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids., PMID:20124407

Citraconic anhydride: a new antigen retrieval solution., PMID:20025485

Datasheet

Document Download

Anti-MYOD1 Antibody (R3D89).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-MYOD1 Antibody (R3D89) [RHD09401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only